YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
Era Biology at ECCMID 2023, Denmark
Era Biology, a leader and pioneer of invasive fungal disease (IFD) diagnostics field, has exhibited at the European Congress of Clinical Microbiology and Infecti...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Day 3 at ISHAM —- FACIS Received High Recognition
New Delhi, India – September 22, 2022 – Genobio with Indian local Partner Bio-State is participating 21th congress of the International Socie...
Era Biology has launched a new product series which is Chemiluminescence Immunoassay (CLIA) detection kit for detecting inflammation and bacterial infections. The kit is run on Full-Automatic Chemi...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...